#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Ischaemic stroke

Recruiting

Registered drug

A Study of Tenecteplase for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Tenecteplase

Contact Research Centre

Allogenic stem cell transplantation

Recruiting

Registered drugNo placebo

Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Blinatumomab

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Clear cell renal cell carcinoma

Recruiting

Registered drug

A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:AB521

Contact Research Centre

K-ras gene mutation+2

Recruiting

Registered drugNo placebo

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

PIK3CA related overgrowth spectrum

Recruiting

InvestigationalNo placebo

Study of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Acute myeloid leukaemia+3

Recruiting

Registered drugNo placebo

Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Busulfan

Contact Research Centre

Diffuse large B-cell lymphoma+2

Recruiting

Registered drugNo placebo

Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Epcoritamab

Contact Research Centre

Diabetic retinal oedema

Recruiting

Registered drugNo placebo

Study of Faricimab treatment to improve vision in patients with diabetic macular edema using adaptive optics imaging

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Faricimab

Contact Research Centre

Neoplasm malignant

Recruiting

InvestigationalNo placebo

Study of BMS-986504 for patients with advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion who have previously received treatment

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE

Contact Research Centre

Atrial fibrillation+1

Recruiting

Registered drugNo placebo

Study of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Flecainide Acetate

Contact Research Centre

Cardiac failure acute

Recruiting

Registered drug

Study of empagliflozin compared to placebo in patients with acute decompensated heart failure who are already taking SGLT2 inhibitors

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Empagliflozin

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.